Citation: | ZHANG Jing. Analysis on research and development of global cardiovascular drugs in the past 6 years[J]. Journal of China Pharmaceutical University, 2018, 49(6): 760-765. DOI: 10.11665/j.issn.1000-5048.20180619 |
[1] |
Zhongrui Pharmaceutical Business School.Analysis of heart diseases in global and China′s drug market[EB/OL].http://www.sohu.com/a/116303528_495747.
|
[2] |
TOP10 global cardiovascular drugs[N]. Medicine Economic Reporter,2017-10-30,F04.
|
[3] |
The future prospects of cardiovascular drugs are broad,new targets,and new drugs emerge in endlessly[N].Medicine Economic Reporter,2010-09-09.
|
[4] |
Guo YS,Guo ZR.Design of multiple targeted drugs[J].Acta Pharm Sin,2009,44(3):276-281.
|
[5] |
The modernization of Chinese medicine has made remarkable achievements in the past twenty years[EB/OL].(2017-07-06)[2018-07-01] https://www.sohu.com/a/155049765_390536.
|
[1] | SHUAI Yubing, WANG Qiudan, HE Tianyu, CAO Lijuan. Mitofusin 2: an emerging drug target[J]. Journal of China Pharmaceutical University, 2025, 56(1): 1-9. DOI: 10.11665/j.issn.1000-5048.2024041001 |
[2] | DU Fenghua, DONG Zhengchuan, CHEN Leyuan, HOU Wenbin, LI Yiliang. Research progress of boron-containing drugs[J]. Journal of China Pharmaceutical University, 2023, 54(2): 159-171. DOI: 10.11665/j.issn.1000-5048.20221101002 |
[3] | YAN Pei, YE Lianbao, CHEN Weiqiang. Progress in therapeutic targets and development of drugs against chronic obstructive pulmonary disease[J]. Journal of China Pharmaceutical University, 2021, 52(2): 144-155. DOI: 10.11665/j.issn.1000-5048.20210202 |
[4] | HE Siyu, SUN Haopeng. Advances of covalently modified drugs[J]. Journal of China Pharmaceutical University, 2017, 48(5): 503-514. DOI: 10.11665/j.issn.1000-5048.20170501 |
[5] | LI Long, KOU Junping. Advances in the research of therapeutic targets and the development of new drugs against arterial thrombosis[J]. Journal of China Pharmaceutical University, 2017, 48(3): 251-258. DOI: 10.11665/j.issn.1000-5048.20170301 |
[6] | HE Wei, QI Haixia, DONG Lei, ZHANG Junfeng. Research advances in drug delivery system targeting immune system[J]. Journal of China Pharmaceutical University, 2015, 46(5): 513-520. DOI: 10.11665/j.issn.1000-5048.20150501 |
[7] | XU Yuhong, CAO Jing. Perspectives on targeted nano-drug carriers for tumor treatment[J]. Journal of China Pharmaceutical University, 2013, 44(6): 494-503. DOI: 10.11665/j.issn.1000-5048.20130602 |
[8] | ZHAO Hong-ping, JIANG Hong-min, XIANG Bing-ren. Analysis on the hot spot targets and tendency of the global cardiovascular drug development in recent 5 years[J]. Journal of China Pharmaceutical University, 2012, 43(6): 573-576. |
[9] | KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15. |
[10] | Application of pharmacometrics in drug development and therapeutic drug monitoring[J]. Journal of China Pharmaceutical University, 2010, 41(1): 91-96. |